The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Stem Cell Exosome Therapeutic Market 2025 by Company, Regions, Type and Application, Forecast to 2029

Global Stem Cell Exosome Therapeutic Market 2025 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1752629

No of Pages : 110

Ask Your Query

Synopsis
The global Stem Cell Exosome Therapeutic market size was valued at USD 157.4 million in 2022 and is forecast to a readjusted size of USD 417 million by 2029 with a CAGR of 14.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Exosome therapy involves using exosomes, small vesicles that are naturally produced by stem cells, to deliver therapeutic molecules to specific cells in the body.

This report is a detailed and comprehensive analysis for global Stem Cell Exosome Therapeutic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Stem Cell Exosome Therapeutic market size and forecasts, in consumption value ($ Million), 2018-2029
Global Stem Cell Exosome Therapeutic market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Stem Cell Exosome Therapeutic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Stem Cell Exosome Therapeutic market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Stem Cell Exosome Therapeutic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Stem Cell Exosome Therapeutic market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aegle Therapeutics, Brexogen, Cell Care Therapeutics, CHA Biotech and ExoCoBio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Stem Cell Exosome Therapeutic market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Mesenchymal Stem Cell (MSC)
  • Dendritic Cells
  • Umbilical MSC
  • Others

Market segment by Application

  • Precision Medicine
  • Regenerative Medicine
  • Others

Market segment by players, this report covers

  • Aegle Therapeutics
  • Brexogen
  • Cell Care Therapeutics
  • CHA Biotech
  • ExoCoBio
  • Exopharm
  • OmniSpiant
  • BrainStorm Cell Therapeutics
  • Novadip Biosciences
  • Unicyte AG
  • Exogenus Therapeutics
  • Creative Medical Tech
  • Anjarium Biosciences
  • Capricor Therapeutics
  • Kimera Labs ReNeuron
  • Stem Cell Medicine
  • Codiak Biosciencesare

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Stem Cell Exosome Therapeutic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Stem Cell Exosome Therapeutic, with revenue, gross margin and global market share of Stem Cell Exosome Therapeutic from 2018 to 2023.
Chapter 3, the Stem Cell Exosome Therapeutic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Stem Cell Exosome Therapeutic market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Stem Cell Exosome Therapeutic.
Chapter 13, to describe Stem Cell Exosome Therapeutic research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Stem Cell Exosome Therapeutic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Stem Cell Exosome Therapeutic by Type
1.3.1 Overview: Global Stem Cell Exosome Therapeutic Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Stem Cell Exosome Therapeutic Consumption Value Market Share by Type in 2022
1.3.3 Mesenchymal Stem Cell (MSC)
1.3.4 Dendritic Cells
1.3.5 Umbilical MSC
1.3.6 Others
1.4 Global Stem Cell Exosome Therapeutic Market by Application
1.4.1 Overview: Global Stem Cell Exosome Therapeutic Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Precision Medicine
1.4.3 Regenerative Medicine
1.4.4 Others
1.5 Global Stem Cell Exosome Therapeutic Market Size & Forecast
1.6 Global Stem Cell Exosome Therapeutic Market Size and Forecast by Region
1.6.1 Global Stem Cell Exosome Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Stem Cell Exosome Therapeutic Market Size by Region, (2018-2029)
1.6.3 North America Stem Cell Exosome Therapeutic Market Size and Prospect (2018-2029)
1.6.4 Europe Stem Cell Exosome Therapeutic Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Stem Cell Exosome Therapeutic Market Size and Prospect (2018-2029)
1.6.6 South America Stem Cell Exosome Therapeutic Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Stem Cell Exosome Therapeutic Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Aegle Therapeutics
2.1.1 Aegle Therapeutics Details
2.1.2 Aegle Therapeutics Major Business
2.1.3 Aegle Therapeutics Stem Cell Exosome Therapeutic Product and Solutions
2.1.4 Aegle Therapeutics Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Aegle Therapeutics Recent Developments and Future Plans
2.2 Brexogen
2.2.1 Brexogen Details
2.2.2 Brexogen Major Business
2.2.3 Brexogen Stem Cell Exosome Therapeutic Product and Solutions
2.2.4 Brexogen Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Brexogen Recent Developments and Future Plans
2.3 Cell Care Therapeutics
2.3.1 Cell Care Therapeutics Details
2.3.2 Cell Care Therapeutics Major Business
2.3.3 Cell Care Therapeutics Stem Cell Exosome Therapeutic Product and Solutions
2.3.4 Cell Care Therapeutics Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Cell Care Therapeutics Recent Developments and Future Plans
2.4 CHA Biotech
2.4.1 CHA Biotech Details
2.4.2 CHA Biotech Major Business
2.4.3 CHA Biotech Stem Cell Exosome Therapeutic Product and Solutions
2.4.4 CHA Biotech Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 CHA Biotech Recent Developments and Future Plans
2.5 ExoCoBio
2.5.1 ExoCoBio Details
2.5.2 ExoCoBio Major Business
2.5.3 ExoCoBio Stem Cell Exosome Therapeutic Product and Solutions
2.5.4 ExoCoBio Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 ExoCoBio Recent Developments and Future Plans
2.6 Exopharm
2.6.1 Exopharm Details
2.6.2 Exopharm Major Business
2.6.3 Exopharm Stem Cell Exosome Therapeutic Product and Solutions
2.6.4 Exopharm Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Exopharm Recent Developments and Future Plans
2.7 OmniSpiant
2.7.1 OmniSpiant Details
2.7.2 OmniSpiant Major Business
2.7.3 OmniSpiant Stem Cell Exosome Therapeutic Product and Solutions
2.7.4 OmniSpiant Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 OmniSpiant Recent Developments and Future Plans
2.8 BrainStorm Cell Therapeutics
2.8.1 BrainStorm Cell Therapeutics Details
2.8.2 BrainStorm Cell Therapeutics Major Business
2.8.3 BrainStorm Cell Therapeutics Stem Cell Exosome Therapeutic Product and Solutions
2.8.4 BrainStorm Cell Therapeutics Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BrainStorm Cell Therapeutics Recent Developments and Future Plans
2.9 Novadip Biosciences
2.9.1 Novadip Biosciences Details
2.9.2 Novadip Biosciences Major Business
2.9.3 Novadip Biosciences Stem Cell Exosome Therapeutic Product and Solutions
2.9.4 Novadip Biosciences Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Novadip Biosciences Recent Developments and Future Plans
2.10 Unicyte AG
2.10.1 Unicyte AG Details
2.10.2 Unicyte AG Major Business
2.10.3 Unicyte AG Stem Cell Exosome Therapeutic Product and Solutions
2.10.4 Unicyte AG Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Unicyte AG Recent Developments and Future Plans
2.11 Exogenus Therapeutics
2.11.1 Exogenus Therapeutics Details
2.11.2 Exogenus Therapeutics Major Business
2.11.3 Exogenus Therapeutics Stem Cell Exosome Therapeutic Product and Solutions
2.11.4 Exogenus Therapeutics Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Exogenus Therapeutics Recent Developments and Future Plans
2.12 Creative Medical Tech
2.12.1 Creative Medical Tech Details
2.12.2 Creative Medical Tech Major Business
2.12.3 Creative Medical Tech Stem Cell Exosome Therapeutic Product and Solutions
2.12.4 Creative Medical Tech Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Creative Medical Tech Recent Developments and Future Plans
2.13 Anjarium Biosciences
2.13.1 Anjarium Biosciences Details
2.13.2 Anjarium Biosciences Major Business
2.13.3 Anjarium Biosciences Stem Cell Exosome Therapeutic Product and Solutions
2.13.4 Anjarium Biosciences Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Anjarium Biosciences Recent Developments and Future Plans
2.14 Capricor Therapeutics
2.14.1 Capricor Therapeutics Details
2.14.2 Capricor Therapeutics Major Business
2.14.3 Capricor Therapeutics Stem Cell Exosome Therapeutic Product and Solutions
2.14.4 Capricor Therapeutics Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Capricor Therapeutics Recent Developments and Future Plans
2.15 Kimera Labs ReNeuron
2.15.1 Kimera Labs ReNeuron Details
2.15.2 Kimera Labs ReNeuron Major Business
2.15.3 Kimera Labs ReNeuron Stem Cell Exosome Therapeutic Product and Solutions
2.15.4 Kimera Labs ReNeuron Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Kimera Labs ReNeuron Recent Developments and Future Plans
2.16 Stem Cell Medicine
2.16.1 Stem Cell Medicine Details
2.16.2 Stem Cell Medicine Major Business
2.16.3 Stem Cell Medicine Stem Cell Exosome Therapeutic Product and Solutions
2.16.4 Stem Cell Medicine Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Stem Cell Medicine Recent Developments and Future Plans
2.17 Codiak Biosciencesare
2.17.1 Codiak Biosciencesare Details
2.17.2 Codiak Biosciencesare Major Business
2.17.3 Codiak Biosciencesare Stem Cell Exosome Therapeutic Product and Solutions
2.17.4 Codiak Biosciencesare Stem Cell Exosome Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Codiak Biosciencesare Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Stem Cell Exosome Therapeutic Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Stem Cell Exosome Therapeutic by Company Revenue
3.2.2 Top 3 Stem Cell Exosome Therapeutic Players Market Share in 2022
3.2.3 Top 6 Stem Cell Exosome Therapeutic Players Market Share in 2022
3.3 Stem Cell Exosome Therapeutic Market: Overall Company Footprint Analysis
3.3.1 Stem Cell Exosome Therapeutic Market: Region Footprint
3.3.2 Stem Cell Exosome Therapeutic Market: Company Product Type Footprint
3.3.3 Stem Cell Exosome Therapeutic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Stem Cell Exosome Therapeutic Consumption Value and Market Share by Type (2018-2023)
4.2 Global Stem Cell Exosome Therapeutic Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Stem Cell Exosome Therapeutic Consumption Value Market Share by Application (2018-2023)
5.2 Global Stem Cell Exosome Therapeutic Market Forecast by Application (2024-2029)
6 North America
6.1 North America Stem Cell Exosome Therapeutic Consumption Value by Type (2018-2029)
6.2 North America Stem Cell Exosome Therapeutic Consumption Value by Application (2018-2029)
6.3 North America Stem Cell Exosome Therapeutic Market Size by Country
6.3.1 North America Stem Cell Exosome Therapeutic Consumption Value by Country (2018-2029)
6.3.2 United States Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
6.3.3 Canada Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
6.3.4 Mexico Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Stem Cell Exosome Therapeutic Consumption Value by Type (2018-2029)
7.2 Europe Stem Cell Exosome Therapeutic Consumption Value by Application (2018-2029)
7.3 Europe Stem Cell Exosome Therapeutic Market Size by Country
7.3.1 Europe Stem Cell Exosome Therapeutic Consumption Value by Country (2018-2029)
7.3.2 Germany Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
7.3.3 France Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
7.3.5 Russia Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
7.3.6 Italy Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Exosome Therapeutic Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Stem Cell Exosome Therapeutic Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Stem Cell Exosome Therapeutic Market Size by Region
8.3.1 Asia-Pacific Stem Cell Exosome Therapeutic Consumption Value by Region (2018-2029)
8.3.2 China Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
8.3.3 Japan Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
8.3.4 South Korea Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
8.3.5 India Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
8.3.7 Australia Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
9 South America
9.1 South America Stem Cell Exosome Therapeutic Consumption Value by Type (2018-2029)
9.2 South America Stem Cell Exosome Therapeutic Consumption Value by Application (2018-2029)
9.3 South America Stem Cell Exosome Therapeutic Market Size by Country
9.3.1 South America Stem Cell Exosome Therapeutic Consumption Value by Country (2018-2029)
9.3.2 Brazil Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
9.3.3 Argentina Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Exosome Therapeutic Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Stem Cell Exosome Therapeutic Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Stem Cell Exosome Therapeutic Market Size by Country
10.3.1 Middle East & Africa Stem Cell Exosome Therapeutic Consumption Value by Country (2018-2029)
10.3.2 Turkey Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
10.3.4 UAE Stem Cell Exosome Therapeutic Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Stem Cell Exosome Therapeutic Market Drivers
11.2 Stem Cell Exosome Therapeutic Market Restraints
11.3 Stem Cell Exosome Therapeutic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Stem Cell Exosome Therapeutic Industry Chain
12.2 Stem Cell Exosome Therapeutic Upstream Analysis
12.3 Stem Cell Exosome Therapeutic Midstream Analysis
12.4 Stem Cell Exosome Therapeutic Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock